ctrl K

Price Alert

Maze Therapeutics Inc. (MAZE)

NASDAQ: MAZE · Real-Time Price · USD

13.49

0.14 (1.05%)

At close: Aug 15, 2025, 3:59 PM

13.50

0.07%

After-hours: Aug 15, 2025, 05:38 PM EDT

Maze Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	196.81M	29.16M	99.92M
Short-Term Investments	n/a	n/a	n/a
Long-Term Investments	1.09M	1.09M	1.21M
Other Long-Term Assets	7.87M	1.32M	1.37M
Receivables	n/a	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	4.86M	4.95M	6.23M
Total Current Assets	201.67M	34.11M	106.15M
Property-Plant & Equipment	29.92M	34.98M	41.23M
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	38.87M	37.39M	43.81M
Total Assets	240.54M	71.5M	149.96M
Account Payables	1.94M	2.02M	1.58M
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	4.63M	4.49M	4.32M
Other Current Liabilities	1.39M	2.39M	3.06M
Total Current Liabilities	20.67M	16.32M	20.78M
Long-Term Debt	n/a	20.08M	n/a
Other Long-Term Liabilities	509.06M	383.9M	383.9M
Total Long-Term Liabilities	531.05M	429.04M	411.63M
Total Liabilities	551.73M	445.35M	432.42M
Total Debt	26.63M	49.62M	32.05M
Common Stock	2K	2K	2K
Retained Earnings	-358.43M	-395.69M	-295.27M
Comprehensive Income	n/a	n/a	n/a
Shareholders Equity	-311.18M	-373.85M	-282.46M
Total Investments	1.09M	1.09M	1.21M